Literature DB >> 12767093

cDNA microarray analysis of gene expression in pathologic Stage IA nonsmall cell lung carcinomas.

Haruhiko Nakamura1, Hisashi Saji, Akihiko Ogata, Makoto Hosaka, Masaru Hagiwara, Takamoto Saijo, Norihito Kawasaki, Harubumi Kato.   

Abstract

BACKGROUND: The relationship between altered gene expression and tumor progression in lung carcinoma has yet to be characterized. Gene expression in pathologic Stage IA nonsmall cell lung carcinoma specimens was analyzed using a cDNA microarray.
METHODS: Surgical specimens were used for the current study. The pathologic stage was IA (AJCC) in five tumors, IB in two, IIA in one, IIIA in one, and IIIB in one. Seven tumor specimens were adenocarcinomas and three were squamous cell carcinomas. Paired mRNAs from carcinoma cells and normal lung tissue specimens from the same lobe were labeled with different fluorochromes during cDNA probe synthesis in a reverse-transcription reaction. Both synthesized, labeled cDNA probes were mixed and hybridized to the microarray. The signal intensity of each spot was measured by laser scanner and gene expression was quantified as the tumor-to-normal fluorescence ratio (T:N ratio). The gene was overexpressed when the T:N ratio was greater than 2.0 and underexpressed when the ratio was less than 0.5.
RESULTS: Overall, 40 (9.4%) of the 425 genes evaluated were overexpressed, and 74 genes (17.4%) were underexpressed. In the 5 Stage IA tumor specimens, 31 (7.3%) genes were overexpressed and 76 (17.9%) were underexpressed. For 30 genes (7.1%), expression was different in Stage IA tumor specimens compared with more advanced tumor specimens.
CONCLUSIONS: The cDNA microarray system showed that numerous alterations of gene expression were present in early-stage nonsmall cell lung carcinoma specimens. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767093     DOI: 10.1002/cncr.11406

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer.

Authors:  Roya Navab; Dan Strumpf; Bizhan Bandarchi; Chang-Qi Zhu; Melania Pintilie; Varune Rohan Ramnarine; Emin Ibrahimov; Nikolina Radulovich; Lisa Leung; Malgorzata Barczyk; Devang Panchal; Christine To; James J Yun; Sandy Der; Frances A Shepherd; Igor Jurisica; Ming-Sound Tsao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-07       Impact factor: 11.205

2.  Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study.

Authors:  Jens Neumann; Friedrich Feuerhake; Gian Kayser; Thorsten Wiech; Konrad Aumann; Bernward Passlick; Paul Fisch; Martin Werner; Axel Zur Hausen
Journal:  BMC Cancer       Date:  2010-03-02       Impact factor: 4.430

3.  Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.

Authors:  Feng Jiang; Zhengnan Yin; Nancy P Caraway; Ruiyun Li; Ruth L Katz
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

4.  Protein signature of lung cancer tissues.

Authors:  Michael R Mehan; Deborah Ayers; Derek Thirstrup; Wei Xiong; Rachel M Ostroff; Edward N Brody; Jeffrey J Walker; Larry Gold; Thale C Jarvis; Nebojsa Janjic; Geoffrey S Baird; Sheri K Wilcox
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

5.  Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.

Authors:  Li-Na Zhou; Shi-Cheng Li; Xue-Ying Li; Hong Ge; Hong-Mei Li
Journal:  Thorac Cancer       Date:  2017-12-20       Impact factor: 3.500

6.  PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin.

Authors:  Patrick L Apopa; Lisa Alley; Rosalind B Penney; Konstantinos Arnaoutakis; Mathew A Steliga; Susan Jeffus; Emine Bircan; Banu Gopalan; Jing Jin; Preecha Patumcharoenpol; Piroon Jenjaroenpun; Thidathip Wongsurawat; Nishi Shah; Gunnar Boysen; David Ussery; Intawat Nookaew; Pebbles Fagan; Gurkan Bebek; Mohammed S Orloff
Journal:  Front Microbiol       Date:  2018-08-06       Impact factor: 5.640

Review 7.  Genetic alteration and gene expression modulation during cancer progression.

Authors:  Cathie Garnis; Timon P H Buys; Wan L Lam
Journal:  Mol Cancer       Date:  2004-03-22       Impact factor: 27.401

8.  Can gene expression profiling predict survival for patients with squamous cell carcinoma of the lung?

Authors:  Zhifu Sun; Ping Yang; Marie-Christine Aubry; Farhad Kosari; Chiaki Endo; Julian Molina; George Vasmatzis
Journal:  Mol Cancer       Date:  2004-12-03       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.